JPET Celsis microsomes equal better data

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MARSHALL, E. K.
Right arrow Search for Related Content
PubMed
Right arrow Articles by MARSHALL, E. K., JR.
Journal of Pharmacology And Experimental Therapeutics, Vol. 29, Issue 1, 167-175, 1926
Copyright © 1926 by American Society for Pharmacology and Experimental Therapeutics

STUDIES ON THE CARDIAC OUTPUT OF THE DOG II. THE INFLUENCE OF ATROPINE AND CARBON DIOXIDE ON THE CIRCULATION OF THE UNANESTHETIZED DOG

E. K. MARSHALL JR. 1

1 From the Laboratory of Physiology, The Johns Hopkins University, School of Medicine

The marked increase in pulse rate produced by administration of small doses of atropine is without influence on the minute volume of the circulation in the normal unanesthetized dog.

A moderate increase of the carbon dioxide in the inspired air (3 to 5 per cent) does not change the minute volume, while breathing higher concentrations causes, if anything, a slight decrease.




This article has been cited by other articles:


Home page
 Arch SurgHome page
A. BLALOCK
MECHANISM AND TREATMENT OF EXPERIMENTAL SHOCK: I. SHOCK FOLLOWING HEMORRHAGE
Arch Surg, November 1, 1927; 15(5): 762 - 798.
[Abstract] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1926 by the American Society for Pharmacology and Experimental Therapeutics.